Braveheart Bio, Inc（BRVE）美股招股说明书 S-1（2026-07-30修订版）（英文版）（308页）.pdf

1、S-1/A 1 braveheartbioinc-sx1a.htm S-1/AAs filed with the Securities and Exchange Commission on July 30,2026.Registration No.333-297456UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549Amendment No.1toFORM S-1REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933Braveheart Bio,Inc.(Ex

2、act name of registrant as specified in its charter)Delaware283499-2981994(State or other jurisdiction of incorporation ororganization)(Primary Standard Industrial ClassificationCode Number)(I.R.S.Employer Identification Number)One Letterman Drive,Building A,Suite A4-300San Francisco,CA 94129(415)707

3、 -6312(Address,including zip code,and telephone number,including area code,of registrants principal executive offices)Travis MurdochChief Executive OfficerBraveheart Bio,Inc.One Letterman Drive,Building A,Suite A4-300San Francisco,CA 94129(415)707-6312(Name,address,including zip code,and telephone n

4、umber,including area code,of agent for service)Copies to:Kingsley L.TaftGabriela Morales-RiveraAlicia TschirhartGoodwin Procter LLP100 Northern Ave.Boston,MA 02210(617)570-1000Paul RickeyBraveheart Bio,Inc.One Letterman Drive,Building A,Suite A4-300San Francisco,CA 94129Brian K.RosenzweigAlicia Zhan

5、gCharles A.DobbCovington&Burling LLP30 Hudson YardsNew York,NY 10001(212)841-1000Approximate date of commencement of proposed sale to the public:As soon as practicable after this registration statement becomes effective.If any of the securities being registered on this Form are to be offered on a de

6、layed or continuous basis pursuant to Rule 415 under theSecurities Act of 1933 check the following box.If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,please check the followingbox and list the Securities Act registration statem